Examples of Clinical Use of Botulinum Toxin: A Literature Review

A.K. Zhantleuova, A.S. Karimova, B. Davletov
{"title":"Examples of Clinical Use of Botulinum Toxin: A Literature Review","authors":"A.K. Zhantleuova, A.S. Karimova, B. Davletov","doi":"10.32523/2616-7034-2023-143-2-81-90","DOIUrl":null,"url":null,"abstract":"Botulinum toxin (BoNT), being one of the most toxic substances known to mankind, due to its unique mechanism of action is used as an effective treatment for many diseases, including strabismus, blepharospasm, and hemifacial spasm. BoNT has received particular use as a long-acting analgesic due to its ability to inhibit the exocytosis of pain neuropeptides, including CGRP, Substance P, and modulate the expression of pain-related receptors as TRPV1, NMDA, AMPA, P2X3. Botulinum toxin injections are effective in the treatment of many pain conditions: diabetic neuropathy, chronic migraine, spinal cord injury. This article reviews the possibilities of clinical applications of botulinum toxin based on the analysis of articles in the PubMed database for specific search terms. The keywords “botulinum toxin”, “treatment”, “clinical use”, “pain reduction” were used to obtain references. The possibilities for the clinical use of botulinum toxin are growing every year. Currently, at least 8 commercially available preparations of botulinum toxin types A and B are known, the most recognizable of which are Botox, Dysport, and MyoBloc/NeuroBloc. Future research should focus on improving the safety profile and increasing the efficacy of botulinum toxin-based drugs. New types of botulinum toxin obtained through molecular reengineering will significantly increase its therapeutic efficacy.","PeriodicalId":248021,"journal":{"name":"BULLETIN of the L.N. Gumilyov Eurasian National University. BIOSCIENCE Series","volume":"79 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BULLETIN of the L.N. Gumilyov Eurasian National University. BIOSCIENCE Series","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32523/2616-7034-2023-143-2-81-90","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Botulinum toxin (BoNT), being one of the most toxic substances known to mankind, due to its unique mechanism of action is used as an effective treatment for many diseases, including strabismus, blepharospasm, and hemifacial spasm. BoNT has received particular use as a long-acting analgesic due to its ability to inhibit the exocytosis of pain neuropeptides, including CGRP, Substance P, and modulate the expression of pain-related receptors as TRPV1, NMDA, AMPA, P2X3. Botulinum toxin injections are effective in the treatment of many pain conditions: diabetic neuropathy, chronic migraine, spinal cord injury. This article reviews the possibilities of clinical applications of botulinum toxin based on the analysis of articles in the PubMed database for specific search terms. The keywords “botulinum toxin”, “treatment”, “clinical use”, “pain reduction” were used to obtain references. The possibilities for the clinical use of botulinum toxin are growing every year. Currently, at least 8 commercially available preparations of botulinum toxin types A and B are known, the most recognizable of which are Botox, Dysport, and MyoBloc/NeuroBloc. Future research should focus on improving the safety profile and increasing the efficacy of botulinum toxin-based drugs. New types of botulinum toxin obtained through molecular reengineering will significantly increase its therapeutic efficacy.
肉毒杆菌毒素临床应用实例:文献综述
肉毒杆菌毒素(BoNT)是人类已知的毒性最大的物质之一,由于其独特的作用机制,被用于治疗许多疾病,包括斜视、眼睑痉挛和面肌痉挛。BoNT作为一种长效镇痛药被广泛使用,因为它能够抑制疼痛神经肽(包括CGRP、Substance P)的胞吐,并调节疼痛相关受体(如TRPV1、NMDA、AMPA、P2X3)的表达。肉毒杆菌毒素注射在治疗许多疼痛条件是有效的:糖尿病神经病变,慢性偏头痛,脊髓损伤。这篇文章回顾了肉毒杆菌毒素的临床应用的可能性基于分析文章在PubMed数据库为特定的搜索词。以“肉毒杆菌毒素”、“治疗”、“临床应用”、“减轻疼痛”为关键词进行文献检索。肉毒杆菌毒素临床应用的可能性每年都在增加。目前,已知至少8种A型和B型肉毒杆菌毒素的市售制剂,其中最知名的是Botox、Dysport和MyoBloc/NeuroBloc。未来的研究应侧重于提高肉毒杆菌毒素类药物的安全性和有效性。通过分子重组获得的新型肉毒杆菌毒素将显著提高其治疗效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信